NL-OMON46489
Completed
Not Applicable
Effect of optical quality on retinal thresholds - Effect of optical quality on retinal thresholds
niversitair Medisch Centrum0 sites50 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversitair Medisch Centrum
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Phakic and pseudophakic POAG and PACG patients and phakic PAC patients scheduled for CLE, who visit the ophthalmology clinic at University Medical Center Groningen, that have provided the signed informed consent form and meet the inclusion\-exclusion criteria. Healthy subjects between ages 50 and 75, who have provided the signed informed consent form and returned the questionnaire with results which do not indicate ophthalmic abnormalities.
Exclusion Criteria
- •POAG patients;Visual acuity less than 0\.8
- •Refractive surgery (LASIK, LASEK, RK, PRK, etc.)
- •Non\-glaucomatous visual field loss
- •History of closed or blocked angle
- •Myopia or hyperopia higher than 3D
- •For pseudophakic patients only: IOL model implanted different than TECNIS Monofocal, Model ZCB00 (default lens in UMCG) and preoperative myopia/hyperopia higher than 3D
- •Phakic PAC patients scheduled for CLE;Visual acuity less than 0\.8
- •Refractive surgery (LASIK, LASEK, RK, PRK, etc.)
- •Non\-glaucomatous visual field loss
- •IOL model to be implanted different than TECNIS Monofocal, Model ZCB00 and preoperative myopia higher than 3D;Healthy Subjects;Visual acuity less than 0\.8
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Effect of optical quality on retinal thresholdsGlaucomaNL-OMON21576niversity Medical Center Groningen (UMCG)40
Withdrawn
Not Applicable
Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland DysfunctionModerate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)NCT01692665Yonsei University
Completed
Not Applicable
The Correlation for Improvement of Visual Acuity and QOL after Ranibizumab Treatment for Age-Related Macular Degeneration PatientsAge-related macular degenerationJPRN-UMIN000012013Clinical Research Support Center Kyushu100
Completed
Not Applicable
ormal values of retinal sensitivity determined by macular integrity assessmentegative history for any ocular or systemic diseases.JPRN-UMIN000008237Faculty of Medicine, Kagawa University100
Completed
Not Applicable
Study of effects on the retina morphological changes and vision of Aflibercept intravitreal injection in patients with macular edema due to central retinal vein occlusion.For recurrent or persistent macular edema due to central retinal vein occlusion of the following antiJPRN-UMIN000014116agasaki University Hospital30